5 | Tyrosine Kinase InhibitorsIBA
11/2021
-
01/2014 |
4 | Biomarkers (Surrogate Marker)IBA
01/2017
-
04/2010 |
3 | ErbB Receptors (EGF Receptor)IBA
10/2019
-
01/2017 |
3 | VaccinesIBA
03/2019
-
06/2010 |
3 | Proteins (Proteins, Gene)FDA Link
12/2017
-
12/2008 |
3 | Carboplatin (JM8)FDA LinkGeneric
03/2008
-
01/2006 |
3 | Paclitaxel (Taxol)FDA LinkGeneric
03/2008
-
01/2006 |
2 | NivolumabIBA
07/2023
-
01/2021 |
2 | Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022
-
10/2016 |
2 | CrizotinibIBA
11/2021
-
09/2014 |
2 | Anaplastic Lymphoma KinaseIBA
11/2021
-
01/2020 |
2 | Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2019
-
01/2017 |
2 | Neoplasm Antigens (Tumor Antigens)IBA
03/2019
-
04/2016 |
2 | Dasatinib (BMS 354825)FDA Link
01/2019
-
03/2010 |
2 | 3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA
01/2017
-
10/2016 |
2 | Epidermal Growth Factor (EGF)IBA
01/2014
-
01/2013 |
2 | Canertinib (CI 1033)IBA
09/2007
-
11/2006 |
1 | IpilimumabIBA
07/2023 |
1 | Death Domain ReceptorsIBA
10/2022 |
1 | utomilumabIBA
10/2022 |
1 | CTLA-4 AntigenIBA
10/2022 |
1 | Adenosine (Adenocard)FDA LinkGeneric
01/2022 |
1 | Alanine (L-Alanine)FDA Link
01/2022 |
1 | spartalizumabIBA
01/2022 |
1 | SteroidsIBA
01/2022 |
1 | ensartinibIBA
11/2021 |
1 | Radioisotopes (Radionuclides)IBA
10/2021 |
1 | Chelating AgentsIBA
10/2021 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2021 |
1 | somatostatin receptor 2IBA
10/2021 |
1 | MetalsIBA
10/2021 |
1 | Peptides (Polypeptides)IBA
10/2021 |
1 | Interleukin-2 (IL2)IBA
01/2021 |
1 | RNA (Ribonucleic Acid)IBA
01/2020 |
1 | Formaldehyde (Formol)FDA Link
01/2020 |
1 | Glycerol KinaseIBA
01/2020 |
1 | Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2020 |
1 | AfatinibIBA
01/2019 |
1 | Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
12/2017 |
1 | DNA (Deoxyribonucleic Acid)IBA
12/2017 |
1 | insulin receptor tyrosine kinaseIBA
01/2017 |
1 | Alanine Transaminase (SGPT)IBA
10/2016 |
1 | Topotecan (Hycamtin)FDA LinkGeneric
10/2016 |
1 | Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
04/2016 |
1 | AutoantibodiesIBA
04/2016 |
1 | 1-methyltryptophanIBA
04/2016 |
1 | Immune Checkpoint InhibitorsIBA
12/2015 |
1 | alectinibIBA
09/2014 |
1 | AntigensIBA
01/2013 |
1 | Mucin-1 (CA 15-3 Antigen)IBA
01/2013 |
1 | INGN 225IBA
06/2010 |
1 | Thymidylate SynthaseIBA
04/2010 |
1 | Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
04/2010 |
1 | Hydroxymethyl and Formyl TransferasesIBA
04/2010 |
1 | Polyglutamic Acid (Polyglutamate)IBA
04/2010 |
1 | Phosphotransferases (Kinase)IBA
03/2010 |
1 | Cyclin D3IBA
12/2008 |
1 | Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
12/2008 |
1 | Retinoblastoma ProteinIBA
12/2008 |
1 | Cyclin D1IBA
12/2008 |
1 | Endothelin A ReceptorIBA
03/2008 |